AvenuesAI Limited: Monitoring Agency Report for Q3FY26 Shows No Deviation in Rights Issue Fund Utilization
AvenuesAI Limited's Monitoring Agency Report for Q3FY26 confirms no deviation in Rights Issue fund utilization (₹699.99 crore). Total utilized funds were ₹151.08 crore as of December 31, 2025. Unutilized funds amount to ₹315.47 crore. CARE Ratings verified utilization aligns with stated objects.
This is a standard regulatory filing providing an update on fund utilization. It does not introduce new material information that would significantly impact the company's stock or operations.
The announcement is a routine monitoring agency report confirming no deviation in fund utilization, which is a neutral development.
AvenuesAI Limited (formerly Infibeam Avenues Limited) has submitted its Monitoring Agency Report for the quarter ended December 31, 2025, to the stock exchanges. The report, issued by CARE Ratings Limited, confirms that there has been no variation or deviation in the utilization of funds raised through the company's Rights Issue, which aggregated to ₹699.99 crore.
The Rights Issue period was from July 03, 2025, to July 11, 2025. The company issued 69,99,85,723 partly paid-up equity shares at ₹10 per share, including a premium of ₹9. Investors paid ₹5 per share on application, with the balance payable on final call(s).
As of December 31, 2025, the total utilized amount from the Rights Issue proceeds was ₹151.08 crore. The total unutilized amount stood at ₹315.47 crore, with ₹8.90 crore yet to be received as of the reporting date. The report details the utilization of funds across various objects, including investment in subsidiaries for loan repayment, technology development, and expansion of digital ecosystems, as well as funding for acquisitions and general corporate purposes. A significant portion of the unutilized funds remains invested in fixed deposits and current accounts pending onward utilization.
CARE Ratings Limited, in its report, has confirmed that the utilization during Q3FY26 is in line with the stated objects. The company has also provided clarification regarding the utilization of funds for General Corporate Purposes (GCP), noting that management approval is not required for utilization up to ₹166.10 crore, as per the offer document and the current shortfall in net proceeds.
What to do with a filing like this
AvenuesAI Limited filed this with the NSE as a statutory disclosure, categorised under other regulatory filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by AvenuesAI Limited. Read the original for the full detail.